Moreover, amplifications in iTAP/FRMD8 copy number have been observed in pediatric acute myeloid leukemia patients, particularly within the context of primary chemotherapy resistance (McNeer et al, 2019). Here, FRMD8 is linked to acute myeloid leukemia.